Hullar MAJ, Kahsai OJ, Hill C, et al. Highly Sensitive DNA Testing of Fusobacterium nucleatum in Colorectal Tumors. Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology. 2025;34(8):1377-1385. doi:10.1158/1055-9965.EPI-24-1020
Publications
Peuranheimo P, Kreivi HR, Ollgren J, et al. Increasing incidence and burden of obstructive sleep apnoea in the Finnish population: A cohort study from 2005 to 2019. Respiratory medicine. 2025;244:108155. doi:10.1016/j.rmed.2025.108155
Bragazzi NL, Zhang L, Omarov M, Georgakis MK. Genetic Risk Scores in Stroke Research and Care. Stroke. 2025;56(8):2327-2336. doi:10.1161/STROKEAHA.125.050961
Karam KA, Abohashem S, Lau HC, et al. Stress-related genetic factors modify the effect of socioeconomic status on cardiovascular risk. Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology. 2025;50(9):1327-1335. doi:10.1038/s41386-025-02130-2
Alchoueiry M, Mansour H, Khabibullin D, et al. Targeting KIT With Antibody-Drug Conjugates in Chromophobe Renal Cell Carcinoma. Clinical genitourinary cancer. 2025;23(4):102359. doi:10.1016/j.clgc.2025.102359
Shulman DS, Crompton BD. Emerging Role of Blood-based Biomarkers in Sarcomas. Hematology/oncology clinics of North America. 2025;39(4):679-692. doi:10.1016/j.hoc.2025.04.002
Alchoueiry M, Mansour H, Khabibullin D, et al. Targeting KIT With Antibody-Drug Conjugates in Chromophobe Renal Cell Carcinoma. Clinical genitourinary cancer. 2025;23(4):102359. doi:10.1016/j.clgc.2025.102359
Shulman DS, Crompton BD. Emerging Role of Blood-based Biomarkers in Sarcomas. Hematology/oncology clinics of North America. 2025;39(4):679-692. doi:10.1016/j.hoc.2025.04.002
Kuntz TM, Liu L, Wang K, et al. Comparing the Metagenomic Performance of Stools Collected from Custom Cards and 95% Ethanol in Epidemiologic Studies. Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology. 2025;34(8):1368-1376. doi:10.1158/1055-9965.EPI-25-0157
Medford AJ, Velimirovic M, Gefen Y, et al. Genomic and proteomic profiling of GATA3 mutant metastatic hormone receptor-positive breast cancer and impact on clinical outcomes. Breast cancer research and treatment. 2025;212(3):437-447. doi:10.1007/s10549-025-07710-w